ArticleBMJ (Clinical research ed.)2014
Modern mammography screening and breast cancer mortality: population study.
Article in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline.Systematic reviews · 2024Pooled it
- Breast Cancer Screening Programmes across the WHO European Region: Differences among Countries Based on National Income Level.International journal of environmental research and public health · 2017Pooled it
- The impact of translated reminder letters and phone calls on mammography screening booking rates: Two randomised controlled trials.PloS one · 2020Trial
- Mammography Adherence in African-American Women: Results of a Randomized Controlled Trial.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2016Trial
- Testing a dual-modality system that combines full-field digital mammography and automated breast ultrasound.Clinical imagingTrial
- Long-term effectiveness and overdiagnosis in the NHS breast screening programme: a cohort study with up to 33 years of follow-up.British journal of cancer · 2026Article
- Breast cancer mortality among women who have attended BreastScreen Norway, 1996-2023.Breast cancer research : BCR · 2026Article
- A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score.PloS one · 2026Article
- Breast and cervical cancer screening in a semi-urban African setting: evidence from Franceville, Gabon (2015-2021).Frontiers in oncology · 2026Article
- A Systematic Review of the Cost-Effectiveness of Screening Modalities for Breast Cancer in European Countries.Cancers · 2025Review
- Article
- Identifying breast cancer risk factors and evaluating biennial mammography screening efficacy using big data analysis in Taiwan.Scientific reports · 2025Article
- Article
- DF-dRVFL: A novel deep feature based classifier for breast mass classification.Multimedia tools and applications · 2024Article
- Oestrogen receptor low positive breast cancer: associations with prognosis.Breast cancer research and treatment · 2023Article
- Vision-Transformer-Based Transfer Learning for Mammogram Classification.Diagnostics (Basel, Switzerland) · 2023Article
- Patchless Multi-Stage Transfer Learning for Improved Mammographic Breast Mass Classification.Cancers · 2022Article
- MRI versus Mammography plus Ultrasound in Women at Intermediate Breast Cancer Risk: Study Design and Protocol of the MRIB Multicenter, Randomized, Controlled Trial.Diagnostics (Basel, Switzerland) · 2021Article
- Comparison of clinicopathological characteristics and prognosis in breast cancer patients with different Breast Imaging Reporting and Data System categories.Annals of surgical treatment and research · 2021Article
- Using Risk Stratification to Optimize Mammography Screening in Chinese Women.JNCI cancer spectrum · 2021Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
objectiveTo evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes.
designProspective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years.
participantsAll Norwegian women aged 50-79 between 1986 and 2009.
main outcome measuresMultiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime.
resultsDuring 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening.
conclusionInvitation to modern mammography screening may reduce deaths from breast cancer by about 28%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.